Hovione Adds Large-Scale Spray-Drying Unit
Hovione is installing a new large-scale spray-drying unit in Loures, Portugal, specifically designed to handle high potency APIs and a wide variety of organic solvent systems.
Hovione announced that it is installing a new large-scale spray-drying unit in Loures, Portugal. This new state-of-the-art unit is specifically designed to handle high potency APIs and a wide variety of organic solvent systems. Installation will be carried out in compliance with quality and safety standards.
Spray drying is a widely use technique in the pharmaceutical industry. Its applications range from formulation of poorly soluble drugs to isolating of biopharmaceuticals and production of inhalable dry powder formulations.
The new large-scale commercial facility is expected to be fully operational by March 2016. The unit, which will increase Hovione’s spray-drying capacity, is the first phase of a broad expansion program to widen the company’s offerings and meet customers’ needs. Hovione currently has spray-drying facilities in Portugal, Ireland, and the United States, spanning all requirements fo the pharmaceutical market in terms of scale, bioburden control, and the ability the handle highly potent materials.
Source: Hovione
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
